{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T06:42:05Z","timestamp":1648622525971},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1001\/jamaneurol.2017.3492","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T17:35:12Z","timestamp":1511804112000},"page":"22","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking Eligibility for Experimental Clinical Trials"],"prefix":"10.1001","volume":"75","author":[{"given":"Lauren","family":"Gibbs","sequence":"first","affiliation":[{"name":"Baylor University, Roeland Park, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2017.3492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T17:57:43Z","timestamp":1515434263000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2017.3492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2017.3492","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,1]]}}}